Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-011800
Filing Date
2025-05-02
Accepted
2025-05-02 16:25:44
Documents
1
Period of Report
2025-04-15

Document Format Files

Seq Description Document Type Size
1 form3-05022025_080541.html 3  
1 form3-05022025_080541.xml 3 4088
  Complete submission text file 0001415889-25-011800.txt   5712
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 535 HAROLD AVENUE NE ATLANTA GA 30307
Business Address
Tweardy Samuel David (Reporting) CIK: 0002066396 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36279 | Film No.: 25908964